Patents by Inventor Peter Amersdorfer

Peter Amersdorfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL METHOD FOR IDENTIFYING SPECIFIC MARKER SEQUENCES FOR PROSTATE CANCER
    Publication number: 20140371095
    Abstract: The present invention relates to a novel method for identifying specific marker sequences for diagnosis of prostate cancer and/or for prognosis in prostate cancer, and to the use of the specific marker sequences identified with the aid of this method.
    Type: Application
    Filed: November 14, 2012
    Publication date: December 18, 2014
    Applicant: Protagen AG
    Inventors: Peter Amersdorfer, Angelika Lueking, Axel Kowald, Bettina Schlick, Petra Massoner, Christof Seifart, Georg Schäfer, Helmut Klocker, Peter Schulz-Knappe, Klaus Marquart
  • Marker Sequences for Pancreatic Cancer Diseases, Pancreatic Carcinoma and Use Thereof
    Publication number: 20120264634
    Abstract: The present invention relates to novel marker sequences for pancreatic cancer diseases, pancreatic carcinoma and the diagnostic use thereof together with a method for screening of potential active substances for pancreatic cancer diseases, pancreatic carcinoma by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for pancreatic cancer diseases, pancreatic carcinoma, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: September 29, 2010
    Publication date: October 18, 2012
    Applicant: PROTAGEN Aktiengesellschaft
    Inventors: Peter Amersdorfer, Annabel Höpfner, Angelika Lueking
  • Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
    Patent number: 8263747
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: September 11, 2012
    Assignee: The Regents of the University of California
    Inventors: James D. Marks, Peter Amersdorfer, Ali Razai
  • Therapeutic Monoclonal Antibodies that Neutralize Botulinum Neurotoxins
    Publication number: 20120177663
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Application
    Filed: July 1, 2011
    Publication date: July 12, 2012
    Inventors: James D. Marks, Peter Amersdorfer, Isin Geren, Jianlong Lou, Ali Razai, Maria Consuelo Garcia
  • Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
    Patent number: 7999079
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: August 16, 2011
    Assignee: The Regents of the University of California
    Inventors: James D. Marks, Peter Amersdorfer, Isin Geren, Jianlong Lou, Ali Razai, Maria Consuelo Garcia
  • THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS
    Publication number: 20110171235
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Application
    Filed: December 23, 2009
    Publication date: July 14, 2011
    Inventors: James D. Marks, Peter Amersdorfer, Isin Geren, Jianlong Lou, Ali Razai, Maria Consuelo Garcia
  • THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS
    Publication number: 20090324606
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Application
    Filed: May 19, 2009
    Publication date: December 31, 2009
    Inventors: James D. Marks, Peter Amersdorfer, Isin Nergiz Geren, Ali Razai
  • Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
    Patent number: 7563874
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: July 21, 2009
    Assignee: The Regents of the University of California
    Inventors: James D. Marks, Peter Amersdorfer
  • THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS
    Publication number: 20090123481
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Application
    Filed: January 13, 2009
    Publication date: May 14, 2009
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: James D. Marks, Peter Amersdorfer
  • Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
    Publication number: 20080124328
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Application
    Filed: January 26, 2006
    Publication date: May 29, 2008
    Inventors: James D. Marks, Peter Amersdorfer, Isin Geren, Jianlong Lou, Ali Razai, Maria Consuelos Garcia
  • Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
    Publication number: 20040175385
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Application
    Filed: August 1, 2003
    Publication date: September 9, 2004
    Applicant: The Regents of the University of Carlifornia
    Inventors: James D. Marks, Peter Amersdorfer
  • THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS
    Publication number: 20020155114
    Abstract: This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
    Type: Application
    Filed: August 31, 1998
    Publication date: October 24, 2002
    Inventors: JAMES D. MARKS, PETER AMERSDORFER